Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-03-14

Clinical Trial Update: Mosaic HIV-1 Envelope Trimer Immunogens Administered to People Living with HIV (PLWH) in Africa [EARLY_Phase 1]

View source ↗

Summary

A EARLY Phase 1 clinical trial evaluating Mosaic HIV-1 Envelope Trimer immunogens in people living with HIV in Africa has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mosaic HIV-1 Envelope Trimer Immunogens

Snippet

Sponsor: International AIDS Vaccine Initiative | Conditions: HIV | EARLY_Phase 1 | Status: WITHDRAWN